| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | MO4K3GDN1I |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Hepatocyte growth factor receptor inhibitor | PubMed |
| Primary Target | |
|---|---|
| MET proto-oncogene, receptor tyrosine kinase |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1365287-97-3 |
| ChEMBL | CHEMBL3301578 |
| FDA SRS | MO4K3GDN1I |
| Guide to Pharmacology | 7748 |
CONTENTS